Neofact - Clinical evaluation of an application aid for less-invasive surfactant administration (LISA)

Product description

Neofact, by Lyomark Pharma, is a medical device for neonates suffering from RDS. 
This study shows that the LISA method (less invasive surfactant administration) via Neofact® appears feasible. 

Neofact® makes surfactant application easy and is also suitable for all gestational ages. This was confirmed in the study and the results of the study are convincing.An extremely high success rate could be achieved (95%).


https://pubmed.ncbi.nlm.nih.gov/33023914/
Read more

Specifications

Categories Pharmaceutical Machinery & TechnologyMedical Devices
Sales markets Europe - EU countries
Supplied from Germany

More products from Lyomark Pharma GmbH

View all our products (11)

Products from other suppliers

Neofact - Clinical evaluation of an application aid for less-invasive surfactant administration (LISA)

Contact information

Address

Telephone

Website

View all contact information
AGC Pharma Chemicals Europe

AGC Pharma Chemicals Europe

Leveraging repurposing drugs and continuous manufacturing strategies with Thermo Fisher Scientific

Leveraging repurposing drugs and continuous manufacturing stra...

CAPSULE CORE COMPETENCY

CAPSULE CORE COMPETENCY

Discover Innovation with Softigel by Procaps

Discover Innovation with Softigel by Procaps

DISSOLUTION OF OIL SOFT GELATIN CAPSULES FROM FORMULATION TO ANALYTICAL DEVELOPMENT

DISSOLUTION OF OIL SOFT GELATIN CAPSULES FROM FORMULATION TO A...